Please assess the completion status of the following clinical trial:

Trial Title: Neuromuscular Electrical Stimulation During Immobilization Due to Ankle Fractures

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Unilateral closed ankle fracture (Weber type A, B or C)~* Aged from 18-65 years~* 18.5 \< BMI \< 30 kg/m2~* Undergoing surgical treatment~Exclusion Criteria:~* Additional fractures beside ankle fracture (e.g. multi-trauma following a car accident)~* Use of oral anticoagulants such as vitamin K-antagonists (e.g. acenocoumarol and fenprocoumon) and direct-acting or new oral anticoagulants (e.g. apixaban, dabigatran and rivaroxaban).~* Any family history of thrombosis~* All co-morbidities interacting with mobility and muscle metabolism of the lower limbs (e.g. arthritis, spasticity/rigidity, all neurological disorders and paralysis).~* Myocardial infarction within the last 3 years

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- NMES group (Type: EXPERIMENTAL): Patients will receive twice daily sessions of neuromuscular electrical stimulation (NMES).
- Control group (Type: NO_INTERVENTION): Patients will receive daily visits by the investigator to check progress.

Based on this trial design, predict the completion outcome and termination type (if applicable).